Navigation Links
Lilly's CEO Calls for Reform of Nation's Drug Safety System
Date:10/2/2007

FDA, health care industry, and the medical community collaboration would

share data via a national health IT system

CLEVELAND, Oct. 2 /PRNewswire-FirstCall/ -- Sidney Taurel, chairman and chief executive officer, Eli Lilly and Company (NYSE: LLY), in a speech today at the Cleveland Clinic, called on the health care industry, medical community and U.S. government to actively collaborate on a health information technology system that would provide more rapid and useful insights on the effectiveness of medicines while improving drug safety.

His proposal, along with other benefits that would flow from a true healthcare "Information Revolution," was outlined for an audience of some of the nation's medical thought-leaders attending Cleveland Clinic's 2007 Medical Innovations Summit. Taurel was the keynote speaker.

"The use of prescription medicines always will be a matter of balancing benefits and risks," Taurel said. "Fortunately, systems are now within our grasp to more quickly identify both the true benefits and the full extent of risks associated with medicines in widespread use."

Although traditional drug trials will continue to test new hypotheses about medicines after they have reached the market, Taurel outlined how a well-functioning health IT system could serve not only to frame hypothesis for so-called "Phase IV" clinical research, but also become the practical equivalent of massive, real-world trials. Such a system would collect detailed data from day-to-day medical practices and feed insights quickly, seamlessly and at a lower cost to doctors, regulators, and drug manufacturers. The result would be a more accurate picture of a drug's safety and efficacy than exists today.

Taurel also explained that intent of the newly enacted FDA Amendments Act of 2007 is to promote much wider involvement of health plans, academic medical centers and other sponsors in Phase IV research.

"The time is ripe for FDA, the health care industry, and the medical community to collaborate on a reform of our nation's pharmacovigilance system," said Taurel. "Such reform will allow us to speed up the recognition of safety signals and understand the true efficacy of new medicines more quickly."

Taurel noted that to fully realize a better drug safety system would require the large-scale implementation of Electronic Medical Records (EMRs) - patient-specific repositories of clinical information on diagnoses, treatments, and outcomes. Properly "blinded" to protect patient privacy, EMRs ultimately could include genetic information as well, in order to tailor therapies to patient groups in which they work best. He traced some of the obstacles to implementing robust, secure EMRs, and offered solutions.

Taurel explained that as EMR systems build out, they provide what amounts to a 'commons' in which organizations can collaborate to share health information.

For example, Lilly, Pfizer, and Johnson & Johnson are collaborating with 'e-Health Initiative' - a not-for-profit health information technology group - as well as with the Indiana Health Information Exchange and the Partners Healthcare System in Boston. The goal is to test how safety signals can be located and understood using existing data, potentially leading to a better understanding of the risk and benefits of medicines.

"This sort of public-private experiment, along with national standards and regional expansion, will soon create a mass of basic infrastructure that could produce the sort of knowledge that will truly revolutionize patient care," concluded Taurel. "We need to open our minds to the notion that electronic health care data represents a legitimate resource - to which access should in most cases be widespread and easy."

Those attending the talk included clinical, medical affairs and regulatory and business development executives, senior executives at medical device makers and pharmaceutical companies, investment bankers, investors and venture capitalists, researchers and the press.

About the Cleveland Clinic's Medical Innovations Summit Please go to http://www.clevelandclinic.org/innovations/summit/default.htm.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Calls to combat deafness after chemotherapy
2. WHO Calls For Greater Emphasis On Combating AIDS
3. PCT Calls Upon Doctor To Delay Surgeries
4. UN Calls For More Funds For Earthquake Affected
5. MP Calls For Ban On Aspartame
6. Scientist Calls Upon Media To Retract His Work
7. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
8. US Government Calls For Better Drug Supplies
9. Phone Calls Lend Vital Support to Moms of Mentally Ill Children
10. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
11. Mixed Orientation Marriages Calls for Deeper Understanding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has officially broken ... Children’s Hospital. Over 3,000 people looked on as the shovels hit the dirt at ... slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped ...
(Date:5/24/2016)... Los Angeles, CA (PRWEB) , ... May 24, ... ... devoted to everything egg freezing, today announced the official relaunch of its community ... to use their frozen eggs. Eggsurance's mission is to create a safe and ...
(Date:5/24/2016)... ... 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered by Movestrong ... Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold Member. The ... 6:30pm - 7:15pm followed by a small intro to the Oils that can benefit ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in Houston, ... contaminated well water throughout the Houston area. , Heavy floodwaters have led to destroyed ... to contaminants. Residents may not even be aware of the contamination of their water ...
(Date:5/24/2016)... ... May 24, 2016 , ... "ProText Layouts Vol. 3 is ... - CEO of Pixel Film Studios. , ProText Layouts Vol. 3 is a set ... Pro X . With ProText Layouts, video editors can create an lively typography video ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... WASHINGTON , May 23, 2016 The World ... PrePex device to include adolescents aged 13 years, ... MedTech, can be offered for adult and adolescent males in ... Africa . PrePex was the first male circumcision device ... Circ MedTech,s CEO, Eddy Horowitz said: " The ...
(Date:5/23/2016)... 23, 2016   Purdue Pharma L.P.  today ... agreement with Egalet Corporation and Acura Pharmaceuticals, Inc. ... of the agreement the companies will exchange valuable ... three companies to develop and sell several opioid ... agreement reflects the commitment of Purdue Pharma to ...
(Date:5/20/2016)... 20, 2016 According to the 2016 ... increasing demand for affordable healthcare solutions as since the early ... rise. In countries like the US, the healthcare cost rose ... the consumer price index inflation rate stood at an average ... up to 3.62% during the same time period. This can ...
Breaking Medicine Technology: